官方服务：
资源简介：
screening for SARS-CoV-2 for asymptomatic pregnant women
应用场景：
创建时间：
2020-10-19
相关数据集
Detection of silent SARS-CoV-2 infection (S1 File)
Background: To control COVID-19 pandemic is of critical importance to the global public health. To capture the prevalence in an accurate and timely manner and to understand the mode of nosocomial infe
NIAID Data Ecosystem40
Spectrum of symptoms of COVID-19 among cases during pregnancy.
Spectrum of symptoms of COVID-19 among cases during pregnancy.
NIAID Data Ecosystem30
Data_Sheet_1_Blood Test Results of Pregnant COVID-19 Patients: An Updated Case-Control Study.pdf
Background: Coronavirus disease (COVID-19) is a current global public health emergency. However, current research on the blood test results of pregnant women with COVID-19 is insufficient. Methods: A
NIAID Data Ecosystem30
Table_1_sFlt-1 Is an Independent Predictor of Adverse Maternal Outcomes in Women With SARS-CoV-2 Infection and Hypertensive Disorders of Pregnancy.XLSX
BackgroundPreeclampsia (PE) and COVID-19 share a common vascular–endothelial physiopathological pathway that may aggravate or worsen women's outcomes when both coexist. This study aims to evaluate the
NIAID Data Ecosystem30
MOESM4 of Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination
Additional file 4. List of 326 seroreactive P. falciparum and P. vivax polypeptides recognized by antibodies in plasma from exposed villagers and malaria patients in Tak Province, Thailand; and their
NIAID Data Ecosystem30
